TrialSignal
Clinical trial intelligence report
The Effect of Native GLP-1 on Glucose Metabolism in the CNS During Hyperglycemia in Healthy Young Men Assessed by PET
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT01185119-Jul 28, 2026
NCT ID
NCT01185119
Status
COMPLETED
Phase
PHASE2
Sponsor
University of Aarhus
Executive brief
Investment-Ready Snapshot
The Effect of Native GLP-1 on Glucose Metabolism in the CNS During Hyperglycemia in Healthy Young Men Assessed by PET is a PHASE2 clinical asset sponsored by University of Aarhus in Healthy. SEO and diligence focus: native glp-1 (7-36), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT01185119
Indication
Healthy
Modality
small molecule
Target
native glp-1 (7-36)
Intervention
native glp-1 (7-36)
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.